Flemming L. Søndergaard

Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist

Stephen T. Buckley, Tine A. Bækdal, Andreas Vegge et al. · Science Translational Medicine · 2018 · 472 citations

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006

Deirdre Cronin‐Fenton, Flemming L. Søndergaard, Lars Pedersen et al. · British Journal of Cancer · 2010 · 368 citations · Full text

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes

Charlotte Granhall, Morten Donsmark, Thalia Marie Blicher et al. · Clinical Pharmacokinetics · 2018 · 160 citations · Full text

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment

Charlotte Granhall, Flemming L. Søndergaard, Mette S. Thomsen et al. · Clinical Pharmacokinetics · 2018 · 113 citations · Full text

Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes

Torben Biester, Sarah Blaesig, K Remus et al. · Pediatric Diabetes · 2014 · 53 citations

Insulin Degludec, Ultra-long Pharmacokinetic Properties, Obesity +17